Text of LA HR 290 (2026)

HLS 26RS-1895 ORIGINAL 2026 Regular Session HOUSE RESOLUTION 290 BY REPRESENTATIVE DOMANGUE HEALTH: Requests the Louisiana Department of Health to study the effects of gender affirming therapy on mental health 1 A RESOLUTION 2 To urge and request the Louisiana Department of Health to study the potential correlation 3 between medications prescribed for any gender-affirming hormone therapy and the 4 incidence of psychosis and related psychiatric conditions in individuals twenty-six 5 years of age and younger, and to report its findings to the legislature. 6 WHEREAS, the Legislature of Louisiana recognizes the importance of ensuring the 7 health, safety, and well-being of all residents of the state, particularly children, adolescents, 8 and young adults; and 9 WHEREAS, any gender-affirming hormone therapy may involve the administration 10 of medications including but not limited to androgen blockers, estrogen, testosterone, 11 puberty-blocking medications, and related pharmaceutical agents; and 12 WHEREAS, certain medications affecting endocrine and neurological function have 13 been associated in medical literature with possible psychological and psychiatric side effects 14 in some individuals; and 15 WHEREAS, psychosis and related psychiatric symptoms, including hallucinations, 16 severe mood disturbances, and dissociative symptoms, may significantly impair an 17 individual's functioning and quality of life; and 18 WHEREAS, the legislature finds that review and analysis of available scientific and 19 medical evidence concerning any potential relationship between gender-affirming hormone 20 therapy medications and psychiatric outcomes in minors and young adults would be 21 beneficial to healthcare professionals, patients, and families; and Page 1 of 3 HLS 26RS-1895 ORIGINAL HR NO. 290 1 WHEREAS, the Louisiana Department of Health possesses the institutional capacity 2 necessary to conduct or coordinate such a study in consultation with qualified medical 3 professionals, researchers, and mental health experts. 4 THEREFORE, BE IT RESOLVED that the House of Representatives of the 5 Legislature of Louisiana does hereby urge and request the Louisiana Department of Health 6 to study the potential correlation between medications prescribed for gender-affirming 7 hormone therapy and the incidence of psychosis and related psychiatric conditions in 8 individuals twenty-six years of age and younger. 9 BE IT FURTHER RESOLVED that the study should include but not be limited to 10 all of the following: 11 (1) A review of available peer-reviewed medical and scientific literature concerning 12 psychiatric outcomes associated with estrogen and testosterone therapy, androgen blockers, 13 puberty blockers, cross-sex hormones, and related medications. 14 (2) An examination of adverse event data, where available, relating to psychosis, 15 schizophrenia-spectrum disorders, severe mood disorders, dissociative conditions, suicidal 16 ideation, and other significant psychiatric symptoms. 17 (3) Consultation with behavioral health specialists, endocrinologists, 18 obstetrician-gynecologists, psychiatrists and therapists, pediatric specialists, 19 pharmacologists, and other qualified healthcare professionals representing a diversity of 20 medical perspectives. 21 (4) Recommendations, if warranted, regarding informed consent standards, patient 22 screening practices, mental health evaluations, monitoring protocols, and areas requiring 23 additional research. 24 BE IT FURTHER RESOLVED that the Louisiana Department of Health submit a 25 written report of its findings, and if needed, recommendations to the House Committee on 26 Health and Welfare no later than February 1, 2027. 27 BE IT FURTHER RESOLVED that a copy of this Resolution be transmitted to the 28 secretary of the Louisiana Department of Health. Page 2 of 3 HLS 26RS-1895 ORIGINAL HR NO. 290 DIGEST The digest printed below was prepared by House Legislative Services. It constitutes no part of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)] HR 290 Original 2026 Regular Session Domangue Requests the La. Dept. of Health to study the potential correlation between medications prescribed for gender-affirming hormone therapy and the incidence of psychosis conditions in individuals 26 years of age and younger, and to report its findings and recommendations to the legislature by Feb. 1, 2027. Page 3 of 3